Simplify Asset Management Inc. bought a new position in shares of Humana Inc. (NYSE:HUM – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 65,190 shares of the insurance provider’s stock, valued at approximately $24,875,000. Humana makes up approximately 0.4% of Simplify Asset Management Inc.’s investment portfolio, making the stock its 13th largest holding.
A number of other institutional investors have also made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of Humana in the second quarter valued at $4,138,160,000. Pzena Investment Management LLC acquired a new stake in Humana during the 2nd quarter valued at $1,749,014,000. Assenagon Asset Management S.A. increased its stake in Humana by 20,126.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock worth $479,053,000 after buying an additional 1,249,272 shares during the period. Legal & General Group Plc purchased a new stake in Humana during the 2nd quarter worth $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in Humana during the 2nd quarter worth $314,922,000. 92.38% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts have commented on the stock. Cantor Fitzgerald upgraded shares of Humana from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $300.00 to $460.00 in a report on Wednesday, October 7th. Leerink Partners upgraded Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price for the company in a research note on Thursday, July 30th. Zacks Research lowered Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. boosted their price target on Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Finally, Royal Bank Of Canada boosted their price target on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 9th. Twenty-one analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Humana currently has an average rating of “Moderate Buy” and an average price target of $453.30.
Read Our Latest Stock Analysis on HUM
Humana Stock Down 0.8%
HUM stock opened at $411.36 on Thursday. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $456.50. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $49.40 billion, a P/E ratio of 38.92, a PEG ratio of 2.60 and a beta of 0.74. The firm has a 50 day simple moving average of $399.48 and a 200-day simple moving average of $307.32.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business’s revenue was up 26.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.27 earnings per share. On average, equities research analysts predict that Humana Inc. will post 9.03 earnings per share for the current fiscal year.
Humana Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be issued a dividend of $0.8850 per share. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, October 30th. Humana’s dividend payout ratio (DPR) is currently 33.49%.
Humana Profile
Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.
Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.
Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.
Featured Stories
- Five stocks we like better than Humana
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
